Introduction
============

During pregnancy, plasma cortisol levels markedly change with gestational stage ([@ref-21]). However, the influence of maternal glucocorticoid on the foetus is limited because of the activation of placental 11-β-hydroxysteroid dehydrogenase 2 (11-β-HSD2) and subsequent conversion of cortisol to biologically inactive cortisone ([@ref-3]). Clinical conditions such as maternal infection, strict diet, hypoxia, and foetal stress attenuate placental 11-β-HSD2 activity ([@ref-11]), which may increase foetal cortisol levels. Foetal exposure to excessive cortisol might induce pathological conditions such as intrauterine growth restriction (IUGR) and preterm labour ([@ref-15]; [@ref-26]), which are associated with increased risks of short-term mortality and a range of long-term morbidities ([@ref-9]; [@ref-13]; [@ref-23]; [@ref-24]). Increasing evidence suggests that homeostatic regulation is modified by environmental factors during early life, which is recognised as antenatal programming ([@ref-2]). Physiological stress response systems, particularly the hypothalamus-pituitary-adrenal (HPA) axis, have been suggested to play a central pathophysiological role in antenatal programming. Although stress-response actions may provide short-term benefits, the resultant alteration of the HPA axis may yield modified responses that result in the development of disease later in life.

Several studies have shown associations between perinatal physiological stress and attenuated adrenal function during childhood. For example, IUGR and preterm birth are associated with attenuated cortisol secretion at ages between 6 months and 7 years ([@ref-4]; [@ref-8]; [@ref-25]). In contrast, when studied during the neonatal period, paradoxically increased cortisol levels were observed in association with IUGR and preterm birth ([@ref-12]; [@ref-15]; [@ref-22]; [@ref-26]), suggesting that the HPA axis regulation might be altered from activation to suppression at some point during infancy or early childhood. However, thus far, few studies have addressed temporal changes in adrenal function following birth in association with exposure to pathological conditions in utero.

Using a cohort of newborns hospitalised in a neonatal intensive care unit (NICU), we have previously reported that lower cortisol levels were associated with clinical events suggestive of unfavourable foetal/postnatal conditions such as exposure to maternal pregnancy-induced hypertension (PIH), caesarean delivery, and preterm birth ([@ref-17]). Using the same dataset with these studies, we performed a secondary analysis to assess whether maturational changes in cortisol levels after birth vary with the presence of IUGR and other clinical variables suggestive of foetal physiological stress.

Material and Methods
====================

Ethics approval and consent
---------------------------

This study was conducted in compliance with the Declaration of Helsinki and with the approval of the Ethics Committee of Kurume University School of Medicine (13142). Written informed consent was obtained from one parent of each participating newborn.

This cross-sectional observational study was conducted as part of a project that investigated the independent variables of cortisol levels and their diurnal patterns ([@ref-17], [@ref-18]). In an exploratory analysis of the dataset, the foetal-type diurnal pattern was observed on the basis of salivary cortisol levels, which were entrained in antiphase to the adult rhythm. Furthermore, the analysis found that lower cortisol levels were associated with older postnatal age, maternal PIH, caesarean delivery, preterm delivery, mechanical ventilation required at birth, and independence from ventilation support on the study day ([@ref-17]). Feeding-induced elevation of cortisol levels was also noted, which was more prominent following oral feeding and was reduced with prolonged feeding ([@ref-18]).

Study population
----------------

Detailed data on patient recruitment, sample collection, and cortisol assays have been reported previously ([@ref-17], [@ref-18]). In brief, 65 newborns hospitalised in a tertiary NICU were recruited between 30 and 40 weeks (corrected age). Newborns, who were diagnosed with major congenital anomalies or chromosomal aberrations, who had undergone phototherapy within 24 h previously, who had not been weaned from invasive mechanical ventilation and continuous intravenous infusion, and who had received glucocorticoid replacement therapy within 1 week previously, were excluded. Data collection was repeated up to two times for each patient, with a minimum interval of 7 days.

Sample collection and assay
---------------------------

Saliva was collected before and 1 h after regular feeding at 10:00 and 19:00 using an absorbent swab (SalivaBio; Salimetrics LLC, State College, PA, USA). A cortisol assay was performed using an enzyme immunoassay kit (high-sensitivity salivary cortisol enzyme-linked immunosorbent assay kit; Salimetrics LLC, State College, PA, USA). The limit of detection of this assay in our laboratory was 0.19 nmol/L, and the intra- and inter-assay coefficients of variation were 5.43% and 6.41%, respectively.

Clinical variables
------------------

Clinical information was obtained from electronic patient records, including maternal age, maternal body weight, and body-mass index at the time of delivery, gestational age, delivery mode, intravenous tocolysis, premature rupture of membranes, histopathologically confirmed chorioamnionitis, PIH, multiple gestations, antenatal glucocorticoid administration, birth weight, and its standard score calculated against the standard Japanese birth weight for gestational age ([@ref-14]), IUGR less than the 10th percentile of the norm, sex, Apgar scores, requirement for respiratory support at birth, and predominant type of milk (formula or breast milk) on the day of saliva collection.

Data analysis
-------------

Values are presented as mean (standard deviation), unless otherwise specified. In the current study, only saliva samples collected before (but not after) feeding at 10:00 and 19:00 were considered because of the known influence of feeding on the cortisol levels ([@ref-18]). Interactions between the clinical variables and postnatal age at saliva collection and their relation to salivary cortisol levels were assessed using the generalised estimating equations with gamma distribution modelling (SPSS ver. 20; IBM, Armonk, NY, USA). To minimise the potential influence of adrenal diurnal patterns and the bias from repeated sampling, the timing of saliva sampling (morning/evening and the study date when studied on two different days) was incorporated as a within-subject factor. Statistical significance was assumed when *p* \< 0.003, after correcting for multiple comparisons of 18 variables. For combinations of categorical variables with significant interactions, the simple effect test was performed for cortisol levels among three postnatal ages of ≤5 days, between 6 and 14 days, and \>14 days (defined by the upper and lower quartile) for better clinical translation.

Results
=======

Out of the 65 newborns, two with an insufficient volume of saliva and one who was subsequently diagnosed with a major chromosomal aberration were excluded from the analysis. Subsequently, 124 samples from 62 cumulative newborns (corrected age, 31.7--39.5 weeks; postnatal age, 1--92 days) who were hospitalised because of low birth weight (*n* = 55), maternal hyperthyroidism or hypothyroidism (*n* = 2), or maternal gestational diabetes mellitus (*n* = 5) were considered ([Table 1](#table-1){ref-type="table"}; [Dataset S1](#supp-1){ref-type="supplementary-material"}).
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###### Clinical backgrounds of the study cohort.

![](peerj-07-6368-g002)

  Variables during pregnancy                
  ----------------------------------------- --------------
  Maternal and antenatal variables          
   Intravenous tocolysis                    51 (82.3)
   Pregnancy-induced hypertension           10 (16.1)
   Antenatal glucocorticoid                 29 (46.8)
   Premature rupture of membranes           22 (35.5)
   Chorioamnionitis                         18 (29.0)
   Maternal age (years)                     31.0 ± 6.2
   Maternal height (cm)                     158.2 ± 5.1
   Maternal body weight (kg)                61.1 ± 11.1
   Maternal body-mass index                 24.4 ± 4.1
  Variables at birth                        
   Vaginal delivery                         26 (41.9)
   Multiple births                          15 (24.2)
   Male                                     27 (43.5)
   Gestational age (weeks)                  32.3 ± 3.7
   Birth weight (g)                         1671 ± 579
   Standard score of the birth weight       −0.55 ± 1.13
   Intrauterine growth restriction          20 (32.3)
   Apgar score (1 min)                      6.4 ± 2.5
   Apgar score (5 min)                      8.1 ± 1.5
   Need for mechanical ventilation          31 (50.0)
   Postnatal glucocorticoid                 7 (11.3)
  Variables on the day of saliva sampling   
   Postnatal age (days)                     24.3 ± 22.6
   Corrected age (weeks)                    35.8 ± 1.3
   Predominant breast milk feeding          37 (59.7)

**Note:**

Values are shown as number (%) or mean ± standard deviation.

The main effects of potential antenatal and postnatal physiological stressors on the cortisol levels have been reported previously (See the second paragraph of the Material and Methods section for the brief summary of findings) ([@ref-17]). Significant interactions were observed between postnatal age and the standard score of the body weight (standardised partial regression coefficient, 1.008; 95% confidence interval, 1.004--1.012; *p* \< 0.001), and postnatal age and IUGR (standardised partial regression coefficient, 0.981; 95% confidence interval, 0.968--0.993; *p* = 0.002) ([Table 2](#table-2){ref-type="table"}).
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###### Effect of antenatal stressors on cortisol levels according to postnatal age.

![](peerj-07-6368-g003)

  Clinical conditions                                 Cortisol       Main effects   Interaction with PNA                           
  ------------------------------------ -------------- -------------- -------------- ---------------------- ------- ------- ------- ---------------
  Intravenous tocolysis                Yes            8.79 (8.76)    0.144          0.738                  0.987   0.968   1.006   0.183
  No                                   8.03 (5.04)                                                                                 
  PROM                                 Yes            9.24 (9.52)    0.393          0.006                  0.994   0.979   1.009   0.457
  No                                   8.14 (6.51)                                                                                 
  PIH                                  Yes            6.10 (4.21)    0.259          ***\<0.001***          0.994   0.982   1.005   0.269
  No                                   9.00 (8.12)                                                                                 
  Maternal age                                                       0.442          0.598                  1.000   0.999   1.001   0.962
  Maternal body-mass index                                           0.027          0.004                  1.002   1.000   1.003   0.023
  Maternal body weight                                               0.051          0.014                  1.000   1.000   1.001   0.074
  Chorioamnionitis                     Yes            8.41 (6.65)    0.541          0.003                  1.009   0.997   1.022   0.151
  No                                   8.58 (8.11)                                                                                 
  Antenatal glucocorticoid             Yes            7.29 (6.15)    0.819          0.008                  0.993   0.979   1.008   0.367
  No                                   9.62 (8,72)                                                                                 
  Postnatal glucocorticoid             Yes            6.43 (4.42)    0.870          0.112                  1.005   0.985   1.026   0.618
  No                                   8.80 (7.99)                                                                                 
  Standard score of the birth weight                                 0.022          0.004                  1.008   1.004   1.012   ***\<0.001***
  IUGR                                 Yes            9.23 (7.92)    0.144          ***\<0.001***          0.981   0.968   0.993   ***0.002***
  No                                   8.20 (7.60)                                                                                 
  Multiple pregnancy                   Yes            8.84 (8.74)    0.756          0.182                  1.004   0.982   1.026   0.744
  No                                   8.29 (6.83)                                                                                 
  Vaginal delivery                     Yes            10.37 (9.52)   0.641          0.013                  1.009   0.997   1.020   0.140
  No                                   7.20 (5.76)                                                                                 
  Male sex                             Yes            8.29 (6.83)    0.286          0.005                  0.989   0.976   1.003   0.121
  No                                   8.84 (8.74)                                                                                 
  Gestational age                                                    0.346          0.784                  1.000   0.997   1.002   0.748
  5-min Apgar score \<7                Yes            6.30 (4.56)    0.295          0.059                  1.008   0.992   1.024   0.338
  No                                   8.86 (8.02)                                                                                 
  Mechanical ventilation               Yes            6.76 (5.07)    0.632          0.896                  0.989   0.954   1.026   0.571
  No                                   10.30 (9.34)                                                                                
  Breast milk                          Yes            6.88 (5.52)    0.061          0.032                  1.006   0.992   1.020   0.371
  No                                   10.97 (9.64)                                                                                

**Notes:**

The *p*-values are from the generalised estimating equation (see "Data analysis" in "Material and Methods" for detail), and are presented for the main effects of each independent variable and postnatal age and their interaction. Statistical significance was assumed when *p* \< 0.003, after correcting for multiple comparisons of 18 variables (indicated in bold and italic).

β, standardised partial regression coefficient; IUGR, intrauterine growth restriction; PIH, pregnancy-induced hypertension; PNA, postnatal age; PROM, premature rupture of membranes; SD, standard deviation.

When the simple effect test was performed for newborns with/without IUGR, the cortisol levels were associated with postnatal age in newborns with (but not without) IUGR; cortisol levels at \>14 days were lower than those at ≤5 days and between 6 and 14 days ([Fig. 1](#fig-1){ref-type="fig"}). Subsequently, IUGR newborns showed higher cortisol levels at ≤5 days and paradoxically lower cortisol levels at \>14 days than their peers (both *p* \< 0.001).

![Box plot depicting the interaction between postnatal age and intrauterine growth restriction on cortisol levels.\
IUGR newborns showed higher cortisol levels at ≤5 days and lower cortisol levels at \>14 days compared with their peers. Association between postnatal age and cortisol levels was observed for newborns with IUGR, but not for those without IUGR. Statistical findings are from the simple effect test with Bonferroni correction. Symbols: box, first and third quartiles; bold line, median; perpendicular line, range without outliers; and open circle, extreme outlier less than 1.5 times the interquartile range from the first quartile. Abbreviation: IUGR, intrauterine growth restriction.](peerj-07-6368-g001){#fig-1}

Discussion
==========

Our study suggested that foetal growth is associated with the relationship between postnatal age and cortisol levels in NICU newborns; cortisol levels of newborns with IUGR were higher soon after birth and lower after two weeks compared to those in their peers without IUGR. These findings build on our previous observations from the same dataset, that maternal PIH, caesarean delivery, and preterm birth are associated with lower cortisol levels in newborns hospitalised in the NICU ([@ref-17]).

IUGR and adrenal function after birth
-------------------------------------

Intrauterine growth restriction is associated with an increased incidence of both short-term and long-term morbidities ([@ref-23], [@ref-24]). In newborns with IUGR, the expression of placental 11-β-HDS2 is decreased ([@ref-26]), leading to increased cord blood cortisol levels in newborns with low body/placental weight ([@ref-12]; [@ref-22]). Increased plasma cortisol levels and angiotensin II receptor subtype 1 expression induce constriction of peripheral vessels, leading to growth restriction of the foetal organs ([@ref-19]). Studies further highlighted that antenatal exposure of the foetus to increased cortisol levels contributes to antenatal programming of the HPA axis and other systems, the influence of which is observed throughout (and even after) the developmental process ([@ref-2]; [@ref-10]).

Studies involving children and adults found associations between low birth weight and increased basal cortisol levels ([@ref-5]; [@ref-20]). However, when assessed during early childhood, there were conflicting findings, showing no association ([@ref-6]; [@ref-16]; [@ref-27]) or positive associations ([@ref-7]; [@ref-8]) between body size at birth and cortisol levels. These inconsistent findings may be derived from the relatively wide age range when cortisol levels were assessed, and the heterogeneous backgrounds of the population, for which the influence of the birth weight was evaluated without incorporating gestational age. Our current data suggest the potential presence of dynamic temporal changes in the adrenal function of IUGR newborns. Spontaneous adrenal functioning might be suppressed in growth-restricted foetuses, which causes plasma cortisol levels to diminish rapidly after birth when maternal cortisol is no longer provided.

Because of the observations suggesting accelerated organ maturation of IUGR newborns ([@ref-1]), the rapid postnatal decrease in cortisol levels in IUGR newborns might merely be a hint of the precocious maturation of the HPA axis that occurs with the earlier-than-usual physiological postnatal decrease in cortisol levels. This speculation might be relevant considering previous findings of attenuated HPA functioning during infancy and activated HPA functioning during adolescence and thereafter in IUGR newborns ([@ref-5]; [@ref-8]; [@ref-20]).

Limitations of the study
------------------------

We did not serially obtain multiple saliva samples; temporal changes in cortisol levels were only extrapolated from cross-sectional findings. Because newborns were recruited when their feeding was established, preterm newborns had older postnatal ages than did their near-term/term peers at the time of the study. Our findings need to be re-assessed in future studies, which serially collect saliva samples from the first day of life to at least four weeks. IUGR newborns in the current study cohort exclusively had asymmetrical IUGR, presumably because symmetrical IUGR was excluded from the study cohort when newborns with major congenital anomalies were excluded.

Conclusions
===========

Cortisol levels of newborns were associated with both postnatal age and intrauterine growth. Cortisol levels of newborns with IUGR were higher soon after birth and lower after two weeks than their peers without IUGR. It is possible to speculate that intrauterine growth may alter age-specific cortisol levels via deactivation of the HPA axis within first weeks of life. Future studies should address the impact of IUGR and other perinatal physiological stressors (and their level and duration) on the adrenal function and the development of diseases during adulthood. The potential benefits of care designed to minimise perinatal physiological stressors in these vulnerable newborns also need to be evaluated.
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###### Dataset used for the current study.

Clinical data used in the current study are shown as raw values.

###### 

Click here for additional data file.
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